[Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
D000028:Abortion, Induced; D002584:Cervix Uteri / Q000187:drug effects*; D004106:Dilatation / Q000379:methods; D015237:Dinoprost / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D010919:Placebos; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011460:Prostaglandins F / Q000096:biosynthesis* / Q000097:blood; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D013997:Time Factors
D010919:Placebos; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; C026528:15-ketoprostaglandin F2alpha; C030319:prostaglandin F2alpha 15-methyl ether; D015237:Dinoprost
Vliianie 15-metil-prostaglandina F2 al'fa, primeniaemogo dlia rasshireniia sheĭki matki pered abortom, na sintez éndogennogo prostaglandina F2 al'fa.